Lewes, DE -- (SBWIRE) -- 06/30/2014 -- Report provides comparative analyses, forecasts for development to 2018:
Key Questions Answerd:
- What is the value of the Central European generic and innovative drug market?
- What is the value of the generic and innovative drugs market in Poland, in Romania, Slovakia, the Czech Republic, Hungary and Bulgaria? In which of these countries is the market forecast to experience the fastest growth?
- Which companies are making their mark in the manufacture, development and sale of generic and innovative treatments in each of these six Central European countries?
- How do these markets compare in terms of opportunities and regulatory structures?
Generic and innovative drugs market in Central Europe, comparative analysis, reimbursement policies and development forecasts for 2014-2018 is a comprehensive guide to the market and all its conditions and variables. This unique report defines and compares market conditions and prospects in each country: Poland, Romania, Bulgaria, Slovakia, the Czech Republic, and Hungary.
This informative publication, prepared by Publisher’s experienced team of market analysts, provides and compares all the newest data describing overall market value and specific value and size data for each segment in each country. It examines recent growth using historical and offers detailed forecasts for continued expansion to 2018.
A large portion of the report is dedicated to clarification of regulatory conditions in the generic and innovative drug segments in each country. The text examines current reimbursement procedures and predicted modifications to reimbursement lists and offers a market impact assessment for each. It examines pricing regulations and drug mark up rates, SPCs (supplemental protection certificates), patent expiry periods and data exclusivity regulations and provides VAT rates for these medicines in each market.
This publication also focuses on the leading companies engaged in the development, manufacture and sale of generic and innovative drugs in Central Europe. Informative profiles reveal the size, earnings and product portfolios of these companies, as well as new information about upcoming events and strategic plans.
Top selling generic and innovative drugs in each country are listed in the report, and the specific procedures used by each country to deal with the problems caused by counterfeit preparations are described and analysed.
Generic and innovative drugs market in Central Europe, comparative analysis, reimbursement policies and development forecasts for 2014-2018 is a convenient, accessible and time saving source of business intelligence for producers of generic and innovative drugs in Poland, Slovakia, Hungary, Bulgaria, the Czech Republic and Romania. The report aids users in preparation for corporate market entry, strategic planning, and product portfolio development and adjustment. It is also a definitive resource for banking and investment and consulting professionals with interests in this regional market and in specific areas of the markets in each country.
Users of this document approach business decision making from a truly informed perspective.
Know more about this report at: http://www.marketresearchreports.com/pmr-ltd/generic-and-innovative-drugs-market-central-europe-2014-comparative-analysis-reimbursement
Find other Generic Drugs Reports at: http://www.marketresearchreports.com/generic-drugs
About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Follow us on Vimeo : http://vimeo.com/marketresearchreports